Proposed Data Collection Submitted for Public Comment and Recommendations, 58095-58096 [2022-20601]
Download as PDF
<![CDATA[
58095
Federal Register / Vol. 87, No. 184 / Friday, September 23, 2022 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Respondent
Questionnaires/Applications ..............
Applicants Questionnaire/Application
Applications, Recommendations, and
Other applicant-supporting documentation.
Focus Groups ....................................
Student/Youth ..................................
Parents/Guardians of Applicants .....
School Officials/Community Representatives.
Other Program Surveys ....................
Total ...........................................
Student/Youth;
School Officials;
Student/Youth;
School Officials;
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–20604 Filed 9–22–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–22–22IV; Docket No. CDC–2022–
0112]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled The Muscular
Dystrophy Surveillance, Tracking, and
Research Network (MD STARnet)
Muscular Dystrophy Questionnaire. The
purpose of the proposed study is to
describe the epidemiology of COVID–19
and flu and the experience with pain,
fatigue, pregnancy, and infertility for
adults living with muscular dystrophy
(MD) who are identified through MD
STARnet. Information will be used to
develop interventions that improve the
lives of people with MD and their
families.
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:04 Sep 22, 2022
Jkt 256001
1
1
1
30/60
30/60
30/60
400
400
600
50
1
60/60
50
600
1
30/60
300
........................
........................
........................
1,750
CDC must receive written
comments on or before November 22,
2022.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2022–
0112 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7118; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
DATES:
PO 00000
Frm 00042
Fmt 4703
Response
burden
(in hours)
800
800
1200
Parent/Guardian;
Other.
Parent/Guardian;
Other.
..........................................................
Average
burden/
response
(in hours)
Number of
responses/
respondent
Number of
respondents
Type of survey
Sfmt 4703
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
The Muscular Dystrophy
Surveillance, Tracking, and Research
Network (MD STARnet) Muscular
Dystrophy Questionnaire—New—
National Center on Birth Defects and
Developmental Disabilities (NCBDDD),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Since its establishment in 2002, the
MD STARnet has been a populationbased surveillance system that aims to
identify and collect clinical data on
individuals with muscular dystrophy
(MD) in select surveillance areas. MD
STARnet identifies and collects data on
cases at sources, including healthcare
facilities where patients with MD
E:\FR\FM\23SEN1.SGM
23SEN1
58096
Federal Register / Vol. 87, No. 184 / Friday, September 23, 2022 / Notices
receive care and administrative datasets
such as vital records and hospital
discharge data. While MDs are rare
genetic diseases with an estimated
prevalence of 16.1/100,000, they have a
high impact on affected individuals,
their families, and society. MDs can be
classified into nine major groups:
Duchenne muscular dystrophy (DMD),
Becker muscular dystrophy (BMD),
myotonic dystrophy (DM),
facioscapulohumeral muscular
dystrophy (FSHD), limb-girdle muscular
dystrophy (LGMD), congenital muscular
dystrophy (CMD), Emery-Dreifuss
muscular dystrophy (EDMD), and distal
MD. A recent MD STARnet study has
estimated the combined prevalence for
DMD and BMD to be 1.92–2.48/10,000
generated from the study will provide a
better understanding of: (1) the
occurrence, testing, treatment and
severity of COVID–19 in relation to MD;
(2) vaccination status and reasons for
not receiving COVID–19 and flu
vaccinations; (3) the frequency,
intensity, and management of pain and
fatigue; and (4) the effect of having MD
on pregnancy and fertility on adults
living with MD. Ultimately, this
information can be used to develop
interventions that improve the lives of
people with MD and their families.
CDC requests OMB approval for an
estimated 974 annual burden hours.
There are no costs to respondents other
than their time to participate.
males age 5–9 years old. MD STARnet
aims to improve understanding of MDs
and ultimately the quality of life of
people and their families living with
MD. Individuals with MDs frequently
report pain and fatigue, but studies have
largely been conducted in clinic-based
populations and included the three
most common MDs. Population-based
studies are needed to describe the
frequency and management of pain and
fatigue and their impact on the lives of
individuals with various types of MD.
The purpose of the proposed study is
to describe the epidemiology of COVID–
19 and flu and the experience with pain,
fatigue, pregnancy, and infertility for
adults living with MD who are
identified through MD STARnet. Results
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Form name
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Adult males 18 and over ...................
Adult females 18 and over ................
Total ..................................................
MD STARnet Male Questionnaire ...
MD STARnet Female Questionnaire
...........................................................
1,794
1,574
........................
1
1
........................
15/60
20/60
........................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–20601 Filed 9–22–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number: ll, Room C4–26–05,
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–10146 Notice of Denial of
Medicare Prescription Drug Coverage
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
ADDRESSES:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Comments must be received by
November 22, 2022.
DATES:
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
VerDate Sep<11>2014
17:04 Sep 22, 2022
Jkt 256001
449
525
974
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, please access the CMS PRA
website by copying and pasting the
following web address into your web
browser: https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.
FOR FURTHER INFORMATION CONTACT:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
[Document Identifier: CMS–10146]
AGENCY:
Total burden
hours
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
E:\FR\FM\23SEN1.SGM
23SEN1
]]>Agencies
[Federal Register Volume 87, Number 184 (Friday, September 23, 2022)]
[Notices]
[Pages 58095-58096]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-20601]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-22-22IV; Docket No. CDC-2022-0112]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a proposed information
collection, as required by the Paperwork Reduction Act of 1995. This
notice invites comment on a proposed information collection project
titled The Muscular Dystrophy Surveillance, Tracking, and Research
Network (MD STARnet) Muscular Dystrophy Questionnaire. The purpose of
the proposed study is to describe the epidemiology of COVID-19 and flu
and the experience with pain, fatigue, pregnancy, and infertility for
adults living with muscular dystrophy (MD) who are identified through
MD STARnet. Information will be used to develop interventions that
improve the lives of people with MD and their families.
DATES: CDC must receive written comments on or before November 22,
2022.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0112 by either of the following methods:
Federal eRulemaking Portal: www.regulations.gov. Follow
the instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to www.regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (www.regulations.gov) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7118;
Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
The Muscular Dystrophy Surveillance, Tracking, and Research Network
(MD STARnet) Muscular Dystrophy Questionnaire--New--National Center on
Birth Defects and Developmental Disabilities (NCBDDD), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Since its establishment in 2002, the MD STARnet has been a
population-based surveillance system that aims to identify and collect
clinical data on individuals with muscular dystrophy (MD) in select
surveillance areas. MD STARnet identifies and collects data on cases at
sources, including healthcare facilities where patients with MD
[[Page 58096]]
receive care and administrative datasets such as vital records and
hospital discharge data. While MDs are rare genetic diseases with an
estimated prevalence of 16.1/100,000, they have a high impact on
affected individuals, their families, and society. MDs can be
classified into nine major groups: Duchenne muscular dystrophy (DMD),
Becker muscular dystrophy (BMD), myotonic dystrophy (DM),
facioscapulohumeral muscular dystrophy (FSHD), limb-girdle muscular
dystrophy (LGMD), congenital muscular dystrophy (CMD), Emery-Dreifuss
muscular dystrophy (EDMD), and distal MD. A recent MD STARnet study has
estimated the combined prevalence for DMD and BMD to be 1.92-2.48/
10,000 males age 5-9 years old. MD STARnet aims to improve
understanding of MDs and ultimately the quality of life of people and
their families living with MD. Individuals with MDs frequently report
pain and fatigue, but studies have largely been conducted in clinic-
based populations and included the three most common MDs. Population-
based studies are needed to describe the frequency and management of
pain and fatigue and their impact on the lives of individuals with
various types of MD.
The purpose of the proposed study is to describe the epidemiology
of COVID-19 and flu and the experience with pain, fatigue, pregnancy,
and infertility for adults living with MD who are identified through MD
STARnet. Results generated from the study will provide a better
understanding of: (1) the occurrence, testing, treatment and severity
of COVID-19 in relation to MD; (2) vaccination status and reasons for
not receiving COVID-19 and flu vaccinations; (3) the frequency,
intensity, and management of pain and fatigue; and (4) the effect of
having MD on pregnancy and fertility on adults living with MD.
Ultimately, this information can be used to develop interventions that
improve the lives of people with MD and their families.
CDC requests OMB approval for an estimated 974 annual burden hours.
There are no costs to respondents other than their time to participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondents Form name respondents responses per response (in hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
Adult males 18 and over....... MD STARnet Male 1,794 1 15/60 449
Questionnaire.
Adult females 18 and over..... MD STARnet 1,574 1 20/60 525
Female
Questionnaire.
Total......................... ................ .............. .............. .............. 974
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-20601 Filed 9-22-22; 8:45 am]
BILLING CODE 4163-18-P
